{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:43Z","timestamp":1707525343608},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"DOI":"10.7759\/cureus.47708","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T11:21:34Z","timestamp":1698319294000},"source":"Crossref","is-referenced-by-count":0,"title":["Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave\u2019s Disease in Basrah"],"prefix":"10.7759","author":[{"given":"Maher A","family":"Radhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassar T","family":"Alibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies TF","year":"2020","unstructured":"Davies TF, Andersen S, Latif R, et al.. Graves' disease. Nat Rev Dis Primers. 2020, 6:52. 10.1038\/s41572-020-0184-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1306-5","article-title":"Epidemiology, management and outcomes of Graves' disease-real life data","volume":"56","author":"Hussain YS","year":"2017","unstructured":"Hussain YS, Hookham JC, Allahabadia A, Balasubramanian SP. Epidemiology, management and outcomes of Graves' disease-real life data. Endocrine. 2017, 56:568-78. 10.1007\/s12020-017-1306-5","journal-title":"Endocrine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/a-0723-9023","article-title":"Thyrotropin receptor blocking antibodies","volume":"50","author":"Diana T","year":"2018","unstructured":"Diana T, Olivo PD, Kahaly GJ. Thyrotropin receptor blocking antibodies. Horm Metab Res. 2018, 50:853-62. 10.1055\/a-0723-9023","journal-title":"Horm Metab Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.10.011","article-title":"Thyrotoxicosis: diagnosis and management","volume":"94","author":"Sharma A","year":"2019","unstructured":"Sharma A, Stan MN. Thyrotoxicosis: diagnosis and management. Mayo Clin Proc. 2019, 94:1048-64. 10.1016\/j.mayocp.2018.10.011","journal-title":"Mayo Clin Proc"},{"key":"ref5","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"93","author":"Kravets I","year":"2016","unstructured":"Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2016, 93:363-70.","journal-title":"Am Fam Physician"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J. 2018, 7:167-86. 10.1159\/000490384","journal-title":"Eur Thyroid J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_388_21","article-title":"Utility of TSH receptor antibodies in the differential diagnosis of hyperthyroidism in clinical practice","volume":"26","author":"John M","year":"2022","unstructured":"John M, Jagesh R, Unnikrishnan H, Jalaja MM, Oommen T, Gopinath D. Utility of TSH receptor antibodies in the differential diagnosis of hyperthyroidism in clinical practice. Indian J Endocrinol Metab. 2022, 26:32-7. 10.4103\/ijem.ijem_388_21","journal-title":"Indian J Endocrinol Metab"},{"key":"ref9","unstructured":"Graves Disease. (2023). Accessed. October 1, 2023: https:\/\/radiopaedia.org\/articles\/graves-disease?lang=us."},{"key":"ref10","article-title":"Thyroid eye disease","volume":"119","author":"Szelog J","year":"2022","unstructured":"Szelog J, Swanson H, Sniegowski MC, Lyon DB. Thyroid eye disease. Mo Med. 2022, 119:343-50.","journal-title":"Mo Med"},{"key":"ref11","article-title":"Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?","volume":"78","author":"Smit MA","year":"2020","unstructured":"Smit MA, van Kinschot CM, van der Linden J, van Noord C, Kos S. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?. Neth J Med. 2020, 78:55-63.","journal-title":"Neth J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24890","article-title":"Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease","volume":"37","author":"Xu S","year":"2023","unstructured":"Xu S, Shao W, Wu Q, Zhu J, Pan B, Wang B, Guo W. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. J Clin Lab Anal. 2023, 37:e24890. 10.1002\/jcla.24890","journal-title":"J Clin Lab Anal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k10e-199","article-title":"Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system","volume":"57","author":"Kamijo K","year":"2010","unstructured":"Kamijo K. Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system. Endocr J. 2010, 57:895-902. 10.1507\/endocrj.k10e-199","journal-title":"Endocr J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-018-0046-9","article-title":"Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases","volume":"11","author":"Rydzewska M","year":"2018","unstructured":"Rydzewska M, Jaromin M, Pasierowska IE, Sto\u017cek K, Bossowski A. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 2018, 11:2. 10.1186\/s13044-018-0046-9","journal-title":"Thyroid Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-285-8","article-title":"Diagnostic criteria in autoimmune diseases","year":"2010","unstructured":"Diagnostic criteria in autoimmune diseases. Shoenfeld Y, Cervera Ricard, Gershwin MC (ed). Humana Totowa, New Jersey; 2010. 10.1007\/978-1-60327-285-8"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197499-cut-off-value-of-thyrotropin-receptor-antibodies-in-graves-disease-in-basrah","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:56Z","timestamp":1707509276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197499-cut-off-value-of-thyrotropin-receptor-antibodies-in-graves-disease-in-basrah"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.47708","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}